AmacaThera Recognized as Ontario's Life Sciences Rising Star for 2026 AmacaThera has been named Life Sciences Ontario Emerging Company of the Year, marking a significant achievement in drug delivery innovation and partnership.

AmacaThera Recognized as Ontario's Life Sciences Rising Star for 2026 #Canada #Toronto #Pacira_BioSciences #Hydrogel #AmacaThera

AmacaThera and Pacira BioSciences Forge Major Licensing Deal for AMT-143, Valued at Up to $230 Million AmacaThera has secured a monumental licensing agreement with Pacira BioSciences, worth up to $230 million, to advance AMT-143, a non-opioid solution for post-operative pain management.

AmacaThera and Pacira BioSciences Forge Major Licensing Deal for AMT-143, Valued at Up to $230 Million #Canada #Toronto #Pacira_BioSciences #AmacaThera #AMT-143

AmacaThera and Merck Animal Health: Pioneering Innovations in Animal Welfare AmacaThera has joined forces with Merck Animal Health to revolutionize the delivery of medications in veterinary medicine through advanced technology.

AmacaThera and Merck Animal Health: Pioneering Innovations in Animal Welfare #Canada #Toronto #AmacaThera #Merck_Animal_Health #hydrogel_technology

AmacaThera Partners with Global Pharma Giant to Develop Innovative Long-Acting Biologic AmacaThera has announced a groundbreaking collaboration with a leading global pharmaceutical company to create an advanced long-acting biologic. This unique product will leverage their innovative AmacaGel™ hydrogel platform.

AmacaThera Partners with Global Pharma Giant to Develop Innovative Long-Acting Biologic #Canada #Toronto #biotechnology #AmacaThera #AmacaGel

AmacaThera and Major Pharma Partner to Innovate Long-Lasting Biologics with Advanced Delivery Systems AmacaThera has teamed up with a leading pharmaceutical company to develop a single-injection long-acting biologic utilizing its AmacaGel™ delivery system. This collaboration promises to advance drug delivery innovation significantly.

AmacaThera and Major Pharma Partner to Innovate Long-Lasting Biologics with Advanced Delivery Systems #Canada #Toronto #Biologics #AmacaThera #AmacaGel

AmacaThera Partners with Global Pharma for Innovative Biologic Development AmacaThera collaborates with a leading pharmaceutical firm to develop a long-acting biologic using its Amacagel™ hydrogel platform. This partnership spots promising innovations in drug delivery.

AmacaThera Partners with Global Pharma for Innovative Biologic Development #Canada #Toronto #Biologics #AmacaThera #AmacaGel

AmacaThera Partners with Leading Pharma for Innovative Single-Injection Biologic Development AmacaThera announces a groundbreaking collaboration with a major pharmaceutical firm to create a long-acting, single-injection biologic using its innovative AmacaGel™ platform.

AmacaThera Partners with Leading Pharma for Innovative Single-Injection Biologic Development #Canada #Toronto #Biologics #AmacaThera #AmacaGel

AmacaThera Partners with Global Pharma for Advanced Biologics Development Using Innovative Hydrogel Platform In a groundbreaking partnership, AmacaThera collaborates with a leading pharmaceutical company to develop a long-acting biologic via their hydrogel platform, AmacaGel™.

AmacaThera Partners with Global Pharma for Advanced Biologics Development Using Innovative Hydrogel Platform #Canada #Toronto #Hydrogel #AmacaThera #Biologic

AmacaThera Welcomes Dr. Eyal S. Ron to Its Board to Propel Strategic Growth Dr. Eyal S. Ron joins AmacaThera's board to enhance growth and innovation in long-acting therapies, poised to revolutionize pain management.

AmacaThera Welcomes Dr. Eyal S. Ron to Its Board to Propel Strategic Growth #USA #Toronto #AmacaThera #AmacaGel #Eyal_Ron

Dr. Eyal S. Ron Joins AmacaThera Board to Drive Innovation and Growth AmacaThera welcomes Dr. Eyal S. Ron to its board, aiming to boost strategic growth and lead innovations in long-acting therapies with advanced hydrogel technology.

Dr. Eyal S. Ron Joins AmacaThera Board to Drive Innovation and Growth #Canada #Toronto #AmacaThera #AMT-143 #Eyal_S._Ron

Dr. Eyal S. Ron Joins AmacaThera Board to Drive Strategic Growth and Innovation AmacaThera has appointed Dr. Eyal S. Ron to its board to enhance strategic growth and innovation in long-acting therapies, especially in postoperative pain management.

Dr. Eyal S. Ron Joins AmacaThera Board to Drive Strategic Growth and Innovation #Canada #Toronto #AmacaThera #AmacaGel #Eyal_Ron

Dr. Eyal S. Ron Joins AmacaThera to Enhance Long-Acting Therapies Innovation and Growth AmacaThera welcomes Dr. Eyal S. Ron to its Board of Directors as the company aims to innovate and grow its long-acting therapy solutions.

Dr. Eyal S. Ron Joins AmacaThera to Enhance Long-Acting Therapies Innovation and Growth #Canada #Toronto #AmacaThera #Eyal_Ron #AMT-143

Dr. Eyal S. Ron to Enhance Strategic Growth at AmacaThera Board Leading biotech firm AmacaThera has appointed Dr. Eyal S. Ron to its Board of Directors, aiming to boost growth and innovation in long-acting therapies.

Dr. Eyal S. Ron to Enhance Strategic Growth at AmacaThera Board #USA #Toronto #AmacaThera #Dr._Eyal_S._Ron #AmacaGel